Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Cytek Biosciences (CTKB) Shares Issued (2020 - 2026)

Cytek Biosciences filings provide 6 years of Shares Issued readings, the most recent being $446000.0 for Q4 2025.

On a quarterly basis, Shares Issued fell 36.01% to $446000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 million, a 32.57% decrease, with the full-year FY2025 number at $1.1 million, down 32.57% from a year prior.
Shares Issued hit $446000.0 in Q4 2025 for Cytek Biosciences, down from $664000.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $889000.0 in Q4 2023 to a low of $17000.0 in Q4 2021.
Median Shares Issued over the past 5 years was $364000.0 (2022), compared with a mean of $385529.4.
Biggest five-year swings in Shares Issued: skyrocketed 888.24% in 2022 and later tumbled 92.29% in 2025.
Cytek Biosciences' Shares Issued stood at $17000.0 in 2021, then skyrocketed by 888.24% to $168000.0 in 2022, then skyrocketed by 429.17% to $889000.0 in 2023, then fell by 21.6% to $697000.0 in 2024, then tumbled by 36.01% to $446000.0 in 2025.
The last three reported values for Shares Issued were $446000.0 (Q4 2025), $664000.0 (Q2 2025), and $39000.0 (Q1 2025) per Business Quant data.